Pharmaresearch Bio Co (XKRX:217950) Cost of Goods Sold : ₩7,676 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Cost of Goods Sold?

Pharmaresearch Bio Co's cost of goods sold for the six months ended in Dec. 2023 was ₩7,676 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in Dec. 2023 was ₩7,676 Mil.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Pharmaresearch Bio Co's Gross Margin % for the six months ended in Dec. 2023 was 61.68%.

Cost of Goods Sold is also directly linked to Inventory Turnover. Pharmaresearch Bio Co's Inventory Turnover for the six months ended in Dec. 2023 was 3.15.

Pharmaresearch Bio Co Cost of Goods Sold Historical Data

The historical data trend for Pharmaresearch Bio Co's Cost of Goods Sold can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Cost of Goods Sold Chart

Pharmaresearch Bio Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cost of Goods Sold

Get a 7-Day Free Trial

1,317.02

3,933.24

5,247.76

5,689.48

7,676.09

Pharmaresearch Bio Co Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Cost of Goods Sold	Get a 7-Day Free Trial			1,317.02	3,933.24	5,247.76	5,689.48	7,676.09

Pharmaresearch Bio Co Cost of Goods Sold Calculation

Cost of Goods Sold is the aggregate cost of goods produced and sold, and services rendered during the reporting period. It excludes Total Operating Expense, such as Depreciation, Depletion and Amortization and Selling, General, & Admin. Expense.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cost of Goods Sold for the trailing twelve months (TTM) ended in Dec. 2023 was ₩7,676 Mil.

Pharmaresearch Bio Co (XKRX:217950) Cost of Goods Sold Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Pharmaresearch Bio Co's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	(Revenue	-	Cost of Goods Sold)	/	Revenue
	=	(20030.641	-	7676.092)	/	20030.641
	=	61.68 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:

Pharmaresearch Bio Co's Inventory Turnover for the six months ended in Dec. 2023 is calculated as:

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	7676.092	/	2440.516
	=	3.15

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.

Pharmaresearch Bio Co Cost of Goods Sold Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's Cost of Goods Sold provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaresearch Bio Co (XKRX:217950) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Cost of Goods Sold

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494

Website

http://www.pr-bio.co.kr

Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co (XKRX:217950) Headlines

No Headlines